期刊文献+

花生四烯酸氧化应激与非酒精性脂肪性肝病的研究进展 被引量:5

The study progress of arachidonic acid oxidative stress and non-alcoholic fatty liver disease
下载PDF
导出
摘要 非酒精性脂肪性肝病(NAFLD)"二次打击学说"认为,氧化应激、脂质过氧化在肝细胞损伤过程中起重要作用。花生四烯酸(AA)作为重要的炎性脂质介质,通过环氧化酶(COX)、脂氧合酶(LOX)、细胞色素P450三大代谢途径来调控肝细胞线粒体内的氧化应激,导致大量脂酸的氧化及脂质过氧化物的形成,肝内胶原的沉积,加重肝细胞的损伤和肝星状细胞(HSC)激活,最终加快NAFLD进展。通过对AA介导的氧化应激在NAFLD发病机制中作用的进一步深入研究,有可能探索出有效治疗脂肪性肝病的新途径,为阻断NAFLD进展提供有力的理论依据。 NAFLD's "second-hit theory" demonstrated that oxidative stress and lipid peroxidation played an impor- tant role in the liver cell damage.Arachidonic acid (AA),an important inflammatory lipid mediator,can regulate liver mitochondria oxidative stress by the cyclooxygenase (COX),lipoxygenase (LOX) and eytochrome P450 metabolic pathways.AA could lead to fatty acid oxidation,lipid peroxide formation, liver collagen deposition and increased liver cell damage and hepatic stellate cells (HSC) activation.This ultimately accelerated the progress of NAFLD. It will provide a theoretical basis of blocking NAFLD progress.
作者 章烁 阳学风
出处 《中国现代医生》 2013年第34期19-22,共4页 China Modern Doctor
基金 国家自然科学基金(81373465)
关键词 非酒精性脂肪肝 花生四烯酸 氧化应激 活性氧 Nonalcoholie fatty liver disease Arachidonic acid Oxidative stress ROS
  • 相关文献

参考文献4

二级参考文献46

  • 1Feng-ze WANG,Li SHA,Wei-ying ZHANG,Lian-ying WU,Ling QIAO,Nan LI,Xiao-dong ZHANG,Li-hong YE.Involvement of hepatitis B X-interacting protein (HBXIP) in proliferation regulation of cells[J].Acta Pharmacologica Sinica,2007,28(3):431-438. 被引量:16
  • 2Ding S T, Wang J C, Mersmann H J. Effect of unsaturated fatty acids on porcine adipocyte differentiation. Nutr Res, 2003, 23: 1059~ 1069.
  • 3Frühbeck G, Gómez-Ambrosi J, Muruzábal F J, Burrell M A. The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol Endocrinol Metab, 2001,280(6): E827 ~ E847.
  • 4Gregoire F M. Adipocyte differentiation: from fibroblast to endocrine cell. Exp Biol Med, 2001, 226(11): 997 ~ 1002.
  • 5Visscher T L, Seidell J C. The public health impact of obesity. Annu Rev Public Health, 2001, 22:355 ~ 375.
  • 6Hoist D, Grimaldi P A. New factors in the regulation of adipose differentiation and metabolism. Curr Opin Lipidol, 2002, 13(3): 241~245.
  • 7Guerre-Millo M. Adipose tissue hormones. J Endocrinol Invest, 2002,25(10): 855 ~ 861.
  • 8Mater M K, Pan D, Bergen W G, Jump D B. Arachidonic acid inhibits lipogenic gene expression in 3T3-L1 adipocytes through a prostanoid pathway. J Lipid Res, 1998, 39:1327 ~ 1334.
  • 9Habenicht A J R, Salbach P, Goerig M, Zeh W, Janssen-Timmen U,Blattner C, Ling W C, Glomset J A. The LDL receptor pathway delivers arachidonic acid for eicosanoid formation in cells stimulated by plateletderived growth factor. Nature, 1990, 346(6284): 495 ~ 502.
  • 10Tontonoz P, Hu E, Graves R A, Budavari A I, Spiegelman B M.mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.Gene Dev, 1994, 8(10): 1224~ 1234.

共引文献321

同被引文献97

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部